Salvatore Calabrese Insider Profile
4 Followers
Salvatore Calabrese, CFO at Gain Therapeutics, holds 0.00 shares in Gain Therapeutics (Ticker: GANX). Most recently, Salvatore Calabrese Bought 3,000 shares of Gain Therapeutics on May 19, 2022 for an estimated value of $24.30M.
Salvatore Calabrese's Trading History
| GANXGain Therapeutics | May 19, 2022 | CFO | Informative Buy | 24.30M | $0.00 | |
You May Also Like
Salvatore Calabrese insider profile FAQ
What stocks does Salvatore Calabrese hold?
Salvatore Calabrese holds: GANX stocks.
What was Salvatore Calabrese’s latest transaction?
Salvatore Calabrese’s latest transaction was an Informative Buy of $24.30M.
What is Salvatore Calabrese's role in Gain Therapeutics?
Salvatore Calabrese's role in Gain Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
